DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Novotel Mumbai Juhu Beach

2024年9月24日 (火) 午前 8:00 - 2024年9月25日 (水) 午後 6:00

Balraj Sahni Marg, Juhu Beach, Mumbai 400049, India

DIA India Annual Meeting 2024

Confluence of Care: Pharmacovigilance, Clinical Innovation, Regulatory Sciences, and Medical Devices Elevating Patient Safety

Track 2 Session 2: Leveraging Technology in Clinical Research and Regulatory Affairs

Session Chair(s)

Manjusha  Rajarshi

Manjusha Rajarshi

Founder Regulus Healthcare

Partner at roots-simplified Research and Consulting LLP, India

In this session, we will delve into the transformative impact of Artificial Intelligence (AI) on regulatory affairs, exploring how AI technologies are reshaping the landscape of compliance, risk management, and regulatory processes. As the regulatory environment becomes increasingly complex, the integration of AI offers Session 2: Leveraging Technology in Clinical Research and Regulatory Affairs Session Chair: Manjusha Rajarshi In this session, we will delve into the transformative impact of Artificial Intelligence (AI) on regulatory affairs, exploring how AI technologies are reshaping the landscape of compliance, risk management, and regulatory processes. As the regulatory environment becomes increasingly complex, the integration of AI offers unprecedented opportunities for efficiency, accuracy, and proactive compliance. However, it also brings forth new challenges and considerations for regulators and the regulated entities. The session will provide insights into the practical applications of AI along with examples of actual use cases. Regulator’s views will be shared wrt the challenges faced in overseeing AI driven processes and ensuring compliance with existing laws and standards, the need to regulate ensuring accountability, transparency and ethical considerations. The future is exciting and holds tremendous potential and needs to be “handled with utmost care” with collaborative efforts as the landscape continues to evolve.

Speaker(s)

Bhumi  Vyas

DCTs: Opportunities and Challenges

Bhumi Vyas

Clinvigilant Research Private Limited, India

Director

Asmita  Nimkar

Using AI in Regulatory Affairs

Asmita Nimkar

Nimkar 360 Pharma LLP, India

Director

Jayant  Kumar

Regulator’s Challenges in the Digital Era

Jayant Kumar

CDSCO, India

Deputy Drug Controller

Mohit  Mhatre

Additional Contributing Panelist

Mohit Mhatre

GSK, India

Digital Health Delivery Lead

Mamta  Sharma

Additional Contributing Panelist

Mamta Sharma

PAREXEL, India

Director Regulatory Affairs

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。